Dhanvantri Jeevan Rekha (BSE 531043)₹20.85+4.98%Healthcare Service Provider
In the Mar 2026 quarter (standalone), Dhanvantri Jeevan Rekha reported sales of ₹7.25 Cr, up 24.1% from Mar 2025, and net profit of ₹0.31 Cr, up 675.0% year on year. For the year to Mar 2026, sales were ₹25.87 Cr and net profit ₹0.41 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.99 | 4.91 | 5.16 | 5.45 | 5.71 | 5.43 | 5.71 | 5.84 | 5.52 | 5.85 | 7.28 | 7.25 |
| Expenses | 4.76 | 4.88 | 4.69 | 5.44 | 5.46 | 5.19 | 5.52 | 5.80 | 5.38 | 5.92 | 7.00 | 6.87 |
| Operating Profit | 0.24 | 0.04 | 0.48 | 0.02 | 0.26 | 0.25 | 0.20 | 0.05 | 0.15 | −0.08 | 0.30 | 0.40 |
| OPM % | 4.6% | 0.6% | 9.1% | 0.2% | 4.4% | 4.4% | 3.3% | 0.7% | 2.5% | −1.2% | 4.0% | 5.4% |
| Other Income | 0.07 | 0.08 | 0.10 | 0.08 | 0.09 | 0.11 | 0.14 | 0.12 | 0.08 | 0.10 | 0.08 | 0.11 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.25 | 0.26 | 0.21 | 0.19 | 0.18 | 0.17 | 0.18 | 0.08 | 0.16 | 0.17 | 0.20 | 0.20 |
| Profit before tax | 0.06 | −0.16 | 0.37 | −0.11 | 0.17 | 0.18 | 0.16 | 0.09 | 0.07 | −0.15 | 0.18 | 0.31 |
| Tax % | 0.0% | 0.0% | 0.0% | −10.0% | 0.0% | 0.0% | 0.0% | 62.4% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | 0.06 | −0.16 | 0.37 | −0.10 | 0.17 | 0.18 | 0.16 | 0.04 | 0.07 | −0.15 | 0.18 | 0.31 |
| EPS (Rs) | 0.11 | −0.36 | 0.87 | −0.21 | 0.38 | 0.40 | 0.36 | 0.06 | 0.14 | −0.33 | 0.40 | 0.72 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.27 | 11.17 | 13.75 | 16.87 | 18.22 | 9.79 | 16.80 | 17.69 | 20.48 | 22.67 | 25.87 | 25.90 |
| Expenses | 7.82 | 9.55 | 11.92 | 15.63 | 17.59 | 10.56 | 15.30 | 17.14 | 19.65 | 21.96 | 25.17 | 25.17 |
| Operating Profit | 1.46 | 1.64 | 1.86 | 1.24 | 0.67 | −0.76 | 1.51 | 0.59 | 0.85 | 0.73 | 0.77 | 0.77 |
| OPM % | 15.6% | 14.6% | 13.5% | 7.3% | 3.6% | −7.7% | 8.9% | 3.3% | 4.1% | 3.2% | 2.9% | 3.0% |
| Other Income | 0.32 | −0.12 | 0.15 | 0.13 | 0.17 | 0.19 | 0.22 | 0.25 | 0.30 | 0.42 | 0.34 | 0.37 |
| Interest | 0.07 | 0.17 | 0.21 | 0.10 | 0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.28 | 0.38 | 1.11 | 1.14 | 1.11 | 1.05 | 1.03 | 0.97 | 0.88 | 0.57 | 0.70 | 0.73 |
| Profit before tax | 1.42 | 0.98 | 0.68 | 0.12 | −0.33 | −1.64 | 0.68 | −0.16 | 0.26 | 0.57 | 0.41 | 0.41 |
| Tax % | 32.5% | 43.2% | −7.5% | 63.6% | −15.7% | −12.9% | 28.3% | 46.6% | 36.0% | 8.9% | 0.0% | — |
| Exceptional items | 0.00 | −0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 0.96 | 0.56 | 0.74 | 0.06 | −0.27 | −1.43 | 0.50 | −0.23 | 0.18 | 0.52 | 0.41 | 0.41 |
| EPS (Rs) | 2.31 | 1.33 | 1.77 | 0.11 | −0.62 | −3.45 | 1.19 | −0.53 | 0.40 | 1.23 | 0.97 | 0.93 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.14 | 4.14 | 4.14 | 4.14 | 4.13 | 4.14 | 4.14 | 4.14 | 4.14 | 4.14 | 4.14 | 4.14 |
| Reserves | 4.29 | 5.24 | 5.78 | 6.50 | 6.55 | 6.29 | 4.87 | 5.36 | 5.14 | 5.31 | 5.98 | 6.35 |
| Borrowings | 0.00 | 0.00 | 1.94 | 1.95 | 0.10 | 0.11 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 2.50 | 3.28 | 4.51 | 3.77 | 4.51 | 4.27 | 4.74 | 4.83 | 4.54 | 5.54 | 4.63 | 7.03 |
| Total Liabilities | 10.93 | 12.66 | 16.37 | 16.36 | 15.29 | 14.81 | 13.83 | 14.33 | 13.82 | 14.99 | 14.75 | 17.52 |
| Fixed Assets | 5.04 | 7.78 | 12.04 | 12.24 | 11.40 | 10.65 | 9.70 | 8.83 | 8.51 | 8.12 | 8.39 | 8.54 |
| CWIP | 1.43 | 0.00 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 4.46 | 4.88 | 4.33 | 4.12 | 3.78 | 4.16 | 4.13 | 5.50 | 5.31 | 6.87 | 6.36 | 8.98 |
| Inventories | 0.02 | 0.02 | 0.02 | 0.06 | 0.12 | 0.12 | 0.10 | 0.13 | 0.15 | 0.14 | 0.16 | 0.09 |
| Trade receivables | 0.34 | 0.53 | 0.36 | 0.68 | 1.04 | 0.46 | 1.08 | 1.72 | 2.46 | 1.76 | 1.81 | 2.63 |
| Cash & equivalents | 0.30 | 0.60 | 0.99 | 1.11 | 0.10 | 1.30 | 0.90 | 1.79 | 0.84 | 3.48 | 2.54 | 3.52 |
| Total Assets | 10.93 | 12.66 | 16.37 | 16.36 | 15.29 | 14.81 | 13.83 | 14.33 | 13.82 | 14.99 | 14.75 | 17.52 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.79 | 1.31 | 3.51 | 0.88 | 1.26 | 1.37 | −0.34 | 1.04 | −0.38 | 3.02 | −0.28 | 1.71 |
| Cash from investing activity | −1.42 | −1.34 | −4.01 | −0.58 | −0.32 | −0.15 | 0.00 | −0.07 | −0.57 | −0.40 | −0.67 | −0.75 |
| Cash from financing activity | 0.41 | 0.30 | 0.86 | −0.20 | −1.95 | −0.03 | −0.04 | −0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net cash flow | −0.19 | 0.31 | 0.41 | 0.12 | −1.01 | 1.20 | −0.41 | 0.91 | −0.96 | 2.65 | −0.96 | 0.99 |
| Capex | 1.55 | 1.57 | 5.61 | 1.30 | 0.42 | 0.23 | 0.09 | 0.14 | 0.63 | 0.45 | 0.83 | 0.86 |
| Free cash flow | −0.65 | −0.27 | −1.58 | −0.43 | 0.87 | 1.17 | −0.44 | 0.91 | −1.04 | 2.58 | −1.14 | 0.88 |
| CFO / OP % | 55.1% | 91.1% | 216.1% | 48.1% | 103.1% | 209.1% | 47.1% | 70.1% | −66.9% | 361.1% | −39.9% | 226.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 14 | 20 | 10 | 17 | 21 | 8 | 39 | 36 | 50 | 30 | 28 | 36 |
| Inventory days | — | — | — | 12 | 18 | 12 | — | — | — | — | — | 4 |
| Days payable | — | — | — | 0 | 0 | 0 | — | — | — | — | — | 48 |
| Cash conversion cycle | 15 | 20 | 11 | 30 | 40 | 21 | 40 | 37 | 51 | 31 | 29 | −6 |
| Working capital days | 67 | 57 | −35 | −27 | −17 | −32 | −53 | −25 | −3 | −32 | −17 | −37 |
| ROCE % | 19.7% | 16.7% | 14.9% | 7.2% | 1.9% | −2.6% | −16.4% | 7.4% | −1.5% | 2.8% | 5.8% | 3.9% |
For the Mar 2026 quarter, Dhanvantri Jeevan Rekha reported sales of ₹7.25 Cr, up 24.1% year on year and net profit of ₹0.31 Cr, up 675.0% year on year. The operating margin was 5.4%.
Dhanvantri Jeevan Rekha's sales for the year to Mar 2026 were ₹25.87 Cr; over the last twelve months they were ₹25.90 Cr.
Net profit for the year to Mar 2026 was ₹0.41 Cr, and ₹0.41 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.93.
Dhanvantri Jeevan Rekha reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹3.52 Cr.
Cash from operations was ₹1.71 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.88 Cr.